Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4 (Q28078574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

review article

1 reference

title

Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4 (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Sangdun Choi

series ordinal

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

1 reference

13 November 2016

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

volume

21

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

issue

11

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

27 March 2020

copyright license

start time

13 November 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The protein kinase complement of the human genome

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Genetic variation in Toll-like receptors and disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-M is a negative regulator of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Oncogenically active MYD88 mutations in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Pyogenic bacterial infections in humans with IRAK-4 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Pyogenic bacterial infections in humans with MyD88 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Cutting edge: expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

TLR2 and TLR4 in autoimmune diseases: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

New Insights in the Immunobiology of IL-1 Family Members

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Cutting edge: molecular structure of the IL-1R-associated kinase-4 death domain and its implications for TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-4 inhibitors for inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-4 inhibitors. Part 1: a series of amides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK4 inhibition to shut down TLR signaling in autoimmunity and MyD88-dependent lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Predicting inactive conformations of protein kinases using active structures: conformational selection of type-II inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Rational design of inhibitors that bind to inactive kinase conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Comprehensive analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Endogenous TLR ligands and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Immunodeficiency in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

IRAK signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Interleukin-1 Receptor-Associated Kinase 1/4 as a Novel Target for Inhibiting Neointimal Formation After Carotid Balloon Injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Cellular and humoral aberrations in a kindred with IL-1 receptor–associated kinase 4 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES21111529

Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation

21 January 2018

1 reference

12 December 2020

IRAK4 in TLR/IL-1R signaling: possible clinical applications

1 reference

12 December 2020

A novel benzenediamine derivate rescued mice from experimental sepsis by attenuating proinflammatory mediators via IRAK4.

1 reference

12 December 2020

Relation between anti-atherosclerotic effects of IRAK4 and modulation of vascular smooth muscle cell phenotype in diabetic rats

1 reference

12 December 2020

10.3390/MOLECULES21111529

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27845762 AND SRC:MED&resulttype=core&format=json

27 March 2020

PubMed publication ID

2 references